Photo from wikipedia
1. Prashanth LK, Jaychandran R, Seetharam R, Iyer RB. Apomorphine: The initial indian experience in relation to response tests and pumps. Ann Indian Acad Neurol 2020. Advanced online publication. doi:… Click to show full abstract
1. Prashanth LK, Jaychandran R, Seetharam R, Iyer RB. Apomorphine: The initial indian experience in relation to response tests and pumps. Ann Indian Acad Neurol 2020. Advanced online publication. doi: 10.4103/aian.AIAN_428_19 2. Weiner WJ. Motor fluctuations in Parkinson’s disease. Rev Neurol Dis 2006;3:101-8. 3. Jenner P, Katzenschlager R. Apomorphine-pharmacological properties and clinical trials in Parkinson’s disease. Parkinsonism Relat Disord 2016;33:S13-S21. 4. Surya N. Parkinson’s disease and apomorphineAn Indian experience. Mov Disord 2007;22:S1-325. 5. Hughes AJ, Lees AJ, Stern GM. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet Lond Engl 1990;336:32-4. 6. Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, et al. Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson’s disease--Clinical practice recommendations. Parkinsonism Relat Disord 2015;21:1023-30. 7. Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, Colosimo C, Eichhorn T, et al. Consensus statement on the role of acute dopaminergic challenge in Parkinson’s disease. Mov Disord Off J Mov Disord Soc 2001;16:197-201.
Journal Title: Annals of Indian Academy of Neurology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!